JO
PAVM icon

John Overdeck’s PAVmed PAVM Stock Holding History

John Overdeck’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-918
Closed -$546K – 2835
2022
Q1 		$546K Sell
918
-2,984
-76% -$2.22M ﹤0.01% 1979
2021
Q4 		$4.32M Buy
+3,902
New +$8.48M 0.01% 1280
2021
Q3 		– Sell
-162
Closed -$466K – 4579
2021
Q2 		$466K Sell
162
-277
-63% -$654K ﹤0.01% 3169
2021
Q1 		$878K Buy
+439
New +$660K ﹤0.01% 2438

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Overdeck's PAVM Position: Q2 2022 in Review

John Overdeck sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 918 shares — an estimated $546K sold.

John Overdeck first reported a position in PAVM in Q1 2021 and held it in 4 quarters. The position peaked at $4.32M in Q4 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • John Overdeck reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • John Overdeck sold 918 PAVmed shares in Q2 2022, an estimated $546K.
  • John Overdeck first reported a position in PAVmed in Q1 2021 and held it in 4 quarters.
  • John Overdeck's PAVmed position peaked at $4.32M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.